AngioDynamics Inc. (ANGO) Tops Q3 EPS by 3c, Provides FY11 Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.42 --0%
Revenue Growth %: +6.3%
Financial Fact:
General and administrative: 8.17M
Today's EPS Names:
MLKN, KBH, WOR, More
Revenue Growth %: +6.3%
Financial Fact:
General and administrative: 8.17M
Today's EPS Names:
MLKN, KBH, WOR, More
Join SI Premium – FREE
AngioDynamics Inc. (NASDAQ: ANGO) reported Q3 EPS of $0.15, $0.03 better than the analyst estimate of $0.12. Revenue for the quarter came in at $54.6 million versus the consensus estimate of $53.89 million.
AngioDynamics Inc. sees FY2011 EPS of $0.48-$0.50, versus the consensus of $0.49. AngioDynamics Inc. sees FY2011 revenue of $217-$220 million, versus the consensus of $220.2 million.
AngioDynamics Inc. sees FY2011 EPS of $0.48-$0.50, versus the consensus of $0.49. AngioDynamics Inc. sees FY2011 revenue of $217-$220 million, versus the consensus of $220.2 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vicor raises Q3 2026 revenue guidance on new licensing deal
- Amer Sports raises Q3 2026 outlook, updates long-term targets
- Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
